|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 512 10TH STREET NW |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Douglas Johnson, Legislative Director |
Date | 10/18/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Several abortion-related policy issues pertaining to FY 2012 appropriations bills are reported on the FAM (Family Issues/Abortion/Adoption) pages.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CON
16. Specific lobbying issues
Contacts in opposition to proposed Parents' Rights Amendment ("PRA") (H.J. Res. 3), unless it is revised to prevent certain anti-life legal effects. Contacts in support of specific proposed clarifying language to prevent the PRA from having unintended anti-life effects.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DOC
16. Specific lobbying issues
Contacts in support of preservation into FY 2012 of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds for abortions (with certain exceptions) in the District of Columbia. Contacts in support of possible legislation to extend and codify certain protections for unborn children (no bill introduced in this quarter).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
|
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Contacts in support of No Taxpayer Funding for Abortion Act, S. 906 / H.R. 3. Contacts in support of H.R. 361/S. 165 (Abortion Non-Discrimination Act) and inclusion of this language in the FY 2012 appropriations legislation for DHHS. Contacts in support of legislative proposals to block or reduce federal funds for the Planned Parenthood Federation of America (PPFA), the nation's largest abortion provider. Consultations regarding inclusion of language (continued)
in FY 2012 appropriations bill(s) to curb subsidies for abortion under the Patient Protection and Affordable Care Act (PL 111-148).
Contacts in support of S. 314 (Unborn Child Pain Awareness Act) and potential additional legislation to protect pain-capable unborn children.
Contacts in support of Child Interstate Abortion Notification Act (S. 1241, H.R. 2299).
Consultations regarding drafting of "Heartbeat Informed Consent Act," introduced October 6, 2011, as H.R. 3130. Letter to House in support of Heartbeat Informed Consent Act, September 28, 2011.
Contacts in opposition to H.R. 2543, legislation to invite federal harassment of pregnancy resource centers.
Contacts in support of retention of all pro-life limitations provisions in first FY 2012 continuing resolution, H.R. 2017 (enacted September 30, 2011, PL 112-33), and in regular FY 2012 appropriations bills, including Labor-HHS-Education appropriations bill (H.R. 3070, S. 1599).
Contacts in support of retention of pro-life limitation provisions of Commerce, Justice, State appropriations bill for FY 2012 (H.R. 2596, S. 1572).
Contacts in support of retention of "D.C. Hyde Amendment" and prohibition on abortion coverage in FEHB program in FY 2012 Financial Services appropriations bill (H.R. 2434, S. 1573).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Contacts in support of retention of all past pro-life limitations (including Kemp-Kasten anti-coercion provision) in State, Foreign Operations (SFOPS) appropriations bill for FY 2012 (House bill unnumbered; S. 1601), and in opposition to the Lautenberg Amendment (adopted as Sec. 7086 of S. 1601 by Senate Appropriations Committee on September 21, 2011) to prohibit any president from placing limitations on aid to abortion-promoting foreign organizations. (continued)
Contacts in opposition to funding of the United Nations Population Fund (UNFPA) in foreign operations appropriations measures.
Contacts in support of H.R. 2059, legislation to prohibit any U.S. contribution to the United Nations Population Fund (UNFPA) (approved by the House Foreign Relations Committee on October 5, 2011), including letter to committee members dated September 30, 2011.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Contacts in opposition to the advancement of the following nomination to Article III federal judgeships: Stephen Six, U.S. Court of Appeals for Tenth Circuit.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
See abortion-related policy issues reported under FAM (Family Issues/Abortion/Adoption).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
U.S. HOUSE OF REPRESENTATIVES
Contacts in support of repealing The Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 2) eliminate the authority (continued)
of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 3) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 4) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 5) repeal the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment.
Contacts in support of H.R. 452, Medicare Decisions Accountability Act of 2011, which would repeal the provisions of Public Law 111-148 regarding the Independent Payment Advisory Boards, including eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation.
Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments.
Contacts in regard to potential health reform legislation (not introduced) over concerns related to 1) the authority of any sort of health care commissions ability to restrict access to life-saving care, 2) premium price controls that might reduce the ability of insurance to cover expensive life-saving care, and 3) malpractice limits being made applicable to intentional denial of treatment for discriminatory reasons.
Contacts relating to H.R.1179, Respect for Rights of Conscience Act of 2011, providing assurances that its current language contained safeguards that would prevent the bill from authorizing discriminatory denial of life-saving treatment, or of medically assisted provision of food and fluids, to vulnerable patients, such as those with disabilities.
U.S. SENATE
Contacts in support of repealing The Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 2) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 3) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 4) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 5) repeal the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment.
Contacts in support of H.R. 452, Medicare Decisions Accountability Act of 2011, which would repeal the provisions of Public Law 111-148 regarding the Independent Payment Advisory Boards, including eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation.
Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments. (continued)
U.S. SENATE (continued)
Contacts in regard to potential health reform legislation (not introduced) over concerns related to 1) the authority of any sort of health care commissions ability to restrict access to life-saving care, 2) premium price controls that might reduce the ability of insurance to cover expensive life-saving care, and 3) malpractice limits being made applicable to intentional denial of treatment for discriminatory reasons.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care ratioining are reported under HCR (Health Issues).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
|
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Consultations regarding preserving and enhancing protection of unborn children in federal/military criminal code, including contacts in support of amendment to S. 1145, "Civilian Extraterritorial Jurisdiction (CEJA) Act," a bill to clarify and expand federal criminal jurisidiction over federal contractors and employees outside the U.S., to incorporate 18 U.S.C. 1841 (Unborn Victims of Violence Act), and in opposition to S. 1145 without this revision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
|
Burke (Thomas) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Regarding H.R. 1249, "America Invents Act," contacts in support of Section 33 of the bill, sometimes referred to as the "Weldon Amendment," codying language enacted on appropriations bills since 2004 to bar issuance of patent on a human organism (human embryo). This bill was enacted on September 16, 2011.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Contacts in opposition to H.R. 2376, DeGette-Dent bill to promote federal funding of the types of stem cell research that require the killing of human embryos, including federal funding of human clone-and-kill research. Contacts in support of Section 33 of H.R. 1249, to bar issuance of patents on human organisms (also reported under Copyright/Patent/Trademark).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Megan |
McCrum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TAX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |